Pharmaceuticals & Medical Devices
Featured news
Press Release: Fairer Medicine Prices Could Save European Union 27€ Billion a Year
Europe could save up to €27 billion a year on new medicines if prices were better aligned with real costs and therapeutic value, according to new research using AIM’s Fair Pricing Model. The peer......
Position Paper : The Biotech Act 2026
AIM, the International Association for Mutual Benefit Societies representing statutory and complementary health insurance funds and mutuals in 16 European countries welcomes the Biotech Act proposed b......
AIM is recruiting a Project Manager (Brussels-based)
The International Association of Mutual Benefit Societies (AIM) is seeking a dynamic Project Manager to join its Brussels-based Secretariat. This is a key role within our international team, dedicated......
Other news
Press Release: Fairer Medicine Prices Could Save European Union 27€ Billion a Year
Europe could save up to €27 billion a year on new medicines if price...
Position Paper : The Biotech Act 2026
AIM, the International Association for Mutual Benefit Societies repres...
AIM is recruiting a Project Manager (Brussels-based)
The International Association of Mutual Benefit Societies (AIM) is see...
AIM reacts to the political agreement on the revision of the EU pharmaceutical legislation
The International Association of Mutual Benefit Societies (AIM) acknow...
AIM Releases its Position on the Critical Medicines Act: A Call for Transparent, Sustainable, and Inclusive Measures
The International Association of Mutual Benefit Societies (AIM) has pu...
ECL, BEUC and AIM Urge EU Member States to Prioritise Affordable Medicines in Pharma Package Negotiations
As EU governments engage in critical negotiations on the revision of t...
AIM WELCOMES THE EU CRITICAL MEDICINES ACT AS A STEP TOWARDS EQUITABLE ACCESS AND SUPPLY CHAIN RESILIENCE
The International Association of Mutual Benefit Societies (AIM) welcom...
STATEMENT ON THE EUROPEAN COMMISSION CALL FOR EVIDENCE ON THE CRITICAL MEDICINES ACT
In response to the Commission’s public consultation on the Critical...
A significant hurdle cleared towards the improvement of public health – AIM reacts to the ENVI vote on the pharmaceutical package
AIM welcomes the agreement by the European Parliament’s Committee on...